SC 13D

Company

Solid Biosciences Inc.

Filed

February 8, 2018

Accession Number

0001193125-18-035562

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →